Phase 2 Multiple Sclerosis clinical trials

19 recruiting Phase 2 multiple sclerosis studies in the US. What trial phases mean

Other phases

RecruitingPhase 2NCT06434571

Comparing Telehealth-Delivered CBT-I to Web-Based CBT-I to Enhance Sleep, Reduce Fatigue, and Promote Neuroprotection

Sponsor: University of Kansas Medical Center

Kansas City, KS

RecruitingPhase 2NCT02784210

Effect of Corticosteroids on Inflammation at the Edge of Acute Multiple Sclerosis Plaques

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)

Bethesda, MD

RecruitingPhase 2NCT05104983

Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study

Sponsor: Darcy Krueger

Birmingham, AL · Los Angeles, CA · Palo Alto, CA · +8 more sites

RecruitingPhase 2NCT06782490

A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity

Sponsor: Celgene

Birmingham, AL · Scottsdale, AZ · Aurora, CO · +13 more sites

RecruitingPhase 2NCT07840326

A Phase 2a Study of SUN-627 in Participants With Non-Active Secondary Progressive and Primary Progressive Multiple Sclerosis (SPMS/PPMS)

Sponsor: Sundance Biosciences, Inc.

Atlanta, GA · Raleigh, NC · Columbus, OH

RecruitingPhase 2NCT07002034

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

Sponsor: Reunion Neuroscience Inc

Birmingham, AL · Tucson, AZ · San Diego, CA · +29 more sites

RecruitingPhase 2NCT07142291

PHENOGENE-1A (Cromolyn) Treatment in Patients With Mild to Moderate ALS

Sponsor: PhenoNet, Inc.

Scottsdale, AZ · La Jolla, CA · San Francisco, CA · +2 more sites

RecruitingPhase 2NCT05269628

Mechanisms of Cannabidiol in Persons With MS: the Role of Sleep and Pain Phenotype

Sponsor: Tiffany J. Braley, MD, MS

Ann Arbor, MI

RecruitingPhase 2NCT07497399

Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis

Sponsor: Johns Hopkins University

Baltimore, MD · New York, NY

RecruitingPhase 2NCT06901687

Home-Based Transcranial Direct Current Stimulation (tDCS) for Depression in Multiple Sclerosis (MS)

Sponsor: NYU Langone Health

New York, NY

RecruitingPhase 2NCT06735248

A Study to Investigate Multiple Sclerosis Relapse Prevention With mRNA-1195 Compared With Placebo in Participants Aged 18 to ≤55 Years

Sponsor: ModernaTX, Inc.

Boston, MA · Farmington Hills, MI · Ozark, MO · +5 more sites

RecruitingPhase 2NCT06170970

Solriamfetol for the Treatment of Multiple Sclerosis Fatigue

Sponsor: Johns Hopkins University

Baltimore, MD

RecruitingPhase 2NCT07510607

Hyperpolarized Carbon Metabolic Imaging in Multiple Sclerosis

Sponsor: Ari Green

San Francisco, CA

RecruitingPhase 2NCT02521311

Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)

Sponsor: University of California, San Francisco

San Francisco, CA

RecruitingPhase 2NCT06463743

Metformin as an add-on or Monotherapy in Treatment of Aging People With Multiple Sclerosis (MS)

Sponsor: State University of New York at Buffalo

Buffalo, NY

RecruitingPhase 2NCT06453694

Efgartigimod for the Treatment of Acute Optic Neuritis

Sponsor: Anastasia Vishnevetsky, MD, MPH

Boston, MA

RecruitingPhase 2NCT06890923

Nasal Foralumab in Patients With Non-Active Secondary Progressive Multiple Sclerosis

Sponsor: Tiziana Life Sciences LTD

Boston, MA

Not yet recruitingPhase 2NCT07222956

A Study of Remibrutinib Using MR Imaging in Relapsing or Progressive MS

Sponsor: Moein Amin

Cleveland, OH

Not yet recruitingPhase 2NCT06961383

Study of NG01 Cell Therapy in Secondary Progressive Multiple Sclerosis

Sponsor: NeuroGenesis Ltd.

Miami, FL

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.